These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9262761

  • 1. Ensuring the safety of genotech drugs through implied warranty theory.
    Serra WM.
    Am J Law Med; 1997; 23(2-3):363-81. PubMed ID: 9262761
    [No Abstract] [Full Text] [Related]

  • 2. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT.
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract] [Full Text] [Related]

  • 3. Drug safety reform at the FDA--pendulum swing or systematic improvement?
    McClellan M.
    N Engl J Med; 2007 Apr 26; 356(17):1700-2. PubMed ID: 17435081
    [No Abstract] [Full Text] [Related]

  • 4. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL.
    Food Drug Law J; 2005 Apr 26; 60(2):261-338. PubMed ID: 16094773
    [No Abstract] [Full Text] [Related]

  • 5. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say.
    DerGurahian J.
    Mod Healthc; 2007 Oct 08; 37(40):16. PubMed ID: 18018373
    [No Abstract] [Full Text] [Related]

  • 6. Paying for drug approvals--who's using whom?
    Avorn J.
    N Engl J Med; 2007 Apr 26; 356(17):1697-700. PubMed ID: 17435083
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The impact of FDA reform.
    Trunzo J.
    Med Device Technol; 2003 Apr 26; 14(3):36-7. PubMed ID: 12789699
    [Abstract] [Full Text] [Related]

  • 11. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2008 Sep 29; 73(189):56487-91. PubMed ID: 18985960
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. What ails the FDA?
    Okie S.
    N Engl J Med; 2005 Mar 17; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract] [Full Text] [Related]

  • 14. The Supreme Court, preemption, and malpractice liability.
    Kesselheim AS, Studdert DM.
    N Engl J Med; 2009 Feb 05; 360(6):559-61. PubMed ID: 19196672
    [No Abstract] [Full Text] [Related]

  • 15. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases.
    Shea LL, Hanson A, Guglielmetti TM, Levy K.
    Food Drug Law J; 2007 Feb 05; 62(3):445-72. PubMed ID: 17915388
    [No Abstract] [Full Text] [Related]

  • 16. FDA tightens its grip on drug regulation.
    Coombes R.
    BMJ; 2007 Feb 10; 334(7588):290-1. PubMed ID: 17289729
    [Abstract] [Full Text] [Related]

  • 17. Industry reneges on postmarketing trial commitments.
    Bouchie A.
    Nat Biotechnol; 2003 Jul 10; 21(7):718. PubMed ID: 12833074
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pediatric testing of prescription drugs: the Food and Drug Administration's carrot and stick for the pharmaceutical industry.
    Karst KR.
    Am Univ Law Rev; 2000 Jul 10; 49():739-72. PubMed ID: 11067732
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.